Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
· pharming group n.v.
AI Briefing
- Pharming's leniolisib receives positive CHMP opinion for APDS treatment
- Joenja approved for adult and pediatric patients 12 and older
- Positive CHMP opinion for leniolisib in APDS treatment
Advertisement